AI Tool for Breast Cancer Risk Prediction Available Nationwide
1 report, 1 independent
Updated Oct 6
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Connie Lehman, founder and chief executive officer of Clairity, is a professor of radiology at Harvard Medical School. Her team developed an AI tool that predicts breast cancer risk over the next five years by analyzing patterns in breast tissue from a mammogram. This assessment is available nationwide through Everlywell’s platform.
From everydayhealth.com
Why it matters
The AI tool provides women the opportunity to tailor their screening intensity based on their predicted risk. This advancement in diagnostic technology could change how breast cancer risk is managed and assessed.
From everydayhealth.com
Who's involved
- Harvard Medical SchoolHarvard Medical School is where Connie Lehman serves as a professor of radiology.
Keep exploring
The entities involved
-
Harvard Medical School
medical school in Boston, Massachusetts